A matched blend combining long-acting GHRH analogue activity (CJC-1295 DAC) with the selective ghrelin-mimetic Ipamorelin for clinics that stock a single dual-vial workflow.
Label-first clinic supply presentation

Strength
1 mg per ml each /10 ml
Total API
10 mg each
Form
Vial
Brand
PureVital
Clinical Peptides
CJC-1295 DAC + Ipamorelin dual secretagogue blend
PV-CJC-1295-DAC-IPAMORELIN-BLEN-1MGPERMLEACH10ML
Professional price
$110.99
A matched blend combining long-acting GHRH analogue activity (CJC-1295 DAC) with the selective ghrelin-mimetic Ipamorelin for clinics that stock a single dual-vial workflow. Presentation: 1 mg per ml each /10 ml (Vial); total API 10 mg each. For licensed clinics and practitioners.
PureVital Clinical Formulary — Strength & Volume updates April 2026
Mechanism themes
Receptor and pathway context written for clinic teams.
Clinic-use references
Titration and presentation notes — not patient prescriptions.
Safety & regulatory
Precautions, interactions, and status framing in one monograph.
Clinical monograph
CJC-1295 DAC + Ipamorelin dual secretagogue blend. Structured for licensed clinics — mechanism, clinic-use themes, safety, and package clarity in one place.
Compound family
cjc ipa
A matched blend combining long-acting GHRH analogue activity (CJC-1295 DAC) with the selective ghrelin-mimetic Ipamorelin for clinics that stock a single dual-vial workflow.
Label-first clinic supply presentation
What arrives for this PureVital SKU
GHRH + GHRP combinations are classic in peptide recovery programs. Matched 1 mg/mL each labeling simplifies symmetrical unit dosing.
Educational formulary information for licensed clinics and practitioners only. PureVital presents professional supplement / wellness formulary items — not regular medicines. Final presentation choice, titration, and monitoring remain clinical decisions. Not intended to diagnose, treat, cure, or prevent any disease.
Continue browsing
Same category presentations clinics often review together.